Your browser doesn't support javascript.
loading
Prevalence of Immature Survival Data for Anti-Cancer Drugs Presented to the National Institute for Health and Care Excellence and Impact on Decision Making.
Tai, Ting-An; Latimer, Nicholas R; Benedict, Ágnes; Kiss, Zsofia; Nikolaou, Andreas.
Affiliation
  • Tai TA; School of Health and Related Research, University of Sheffield, Sheffield, England, UK. Electronic address: tinantai@gmail.com.
  • Latimer NR; School of Health and Related Research, University of Sheffield, Sheffield, England, UK.
  • Benedict Á; Modelling and Simulation, Evidera, Budapest, Hungary.
  • Kiss Z; Modelling and Simulation, Evidera, London, England, UK.
  • Nikolaou A; Modelling and Simulation, Evidera, London, England, UK.
Value Health ; 24(4): 505-512, 2021 04.
Article in En | MEDLINE | ID: mdl-33840428
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Technology Assessment, Biomedical / Decision Making / Neoplasms / Antineoplastic Agents Type of study: Guideline / Health_economic_evaluation / Health_technology_assessment / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2021 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Technology Assessment, Biomedical / Decision Making / Neoplasms / Antineoplastic Agents Type of study: Guideline / Health_economic_evaluation / Health_technology_assessment / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2021 Document type: Article Country of publication: United States